PharmacyCodes



Reduced D-penicillamine en es it fr

Reduced D-penicillamine Brand names, Reduced D-penicillamine Analogs

Reduced D-penicillamine Brand Names Mixture

  • No information avaliable

Reduced D-penicillamine Chemical_Formula

C5H11NO2S

Reduced D-penicillamine RX_link

http://www.rxlist.com/cgi/generic3/penicillamine.htm

Reduced D-penicillamine fda sheet

Reduced_D-penicillamine FDA

Reduced D-penicillamine msds (material safety sheet)

Reduced_D-penicillamine MSDS

Reduced D-penicillamine Synthesis Reference

No information avaliable

Reduced D-penicillamine Molecular Weight

149.212 g/mol

Reduced D-penicillamine Melting Point

198.5 oC

Reduced D-penicillamine H2O Solubility

1.11E+005 mg/L

Reduced D-penicillamine State

Solid

Reduced D-penicillamine LogP

-2.09

Reduced D-penicillamine Dosage Forms

Capsule; Tablet

Reduced D-penicillamine Indication

For treatment of Wilson's disease, cystinuria and active rheumatoid arthritis

Reduced D-penicillamine Pharmacology

Penicillamine is a chelating agent used in the treatment of Wilson's disease. It is also used to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis unresponsive to conventional therapy. Penicillamine is used as a form of immunosuppression to treat rheumatoid arthritis. It works by reducing numbers of T-lymphocytes, inhibiting macrophage function, decreasing IL-1, decreasing rheumatoid factor, and preventing collagen from cross-linking. Its use in Wilson's disease, a rare genetic disorder of copper metabolism, relies on its binding to accumulated copper and elimination through urine.

Reduced D-penicillamine Absorption

rapidly but incompletely

Reduced D-penicillamine side effects and Toxicity

No information avaliable

Reduced D-penicillamine Patient Information

No information avaliable

Reduced D-penicillamine Organisms Affected

Humans and other mammals